HEAD JONATHAN FREDERICK 4/A
4/A · OncBioMune Pharmaceuticals, Inc · Filed Mar 14, 2019
Insider Transaction Report
Form 4/AAmended
HEAD JONATHAN FREDERICK
DirectorChief Executive Officer
Transactions
- Award
Series A Preferred Stock
2015-09-02+500,000→ 500,000 total
Footnotes (2)
- [F1]These shares of Series A Preferred were omitted from the reporting person's original Form 4.
- [F2]Received, in addition to shares of common stock of the registrant, in exchange for all of the reporting person's shares of OncBioMune, Inc. ("ONC") common stock in connection with the exchange pursuant to that certain exchange agreement dated as of June 22, 2015, as amended, among the registrant, ONC and the ONC shareholders.